About 2,060 results
Open links in new tab
  1. Lifecycle Examples Learnings from clinical trials define the pathway Post-marketing experience The Following four slides provides a short lifecycle history of some unusual drug entities as examples!

  2. The Drug Development Process | FDA

    The Drug Development Process FDA Review FDA review teams thoroughly examine all of the submitted data related to the drug or device and make a decision to approve or not to approve it. More ...

  3. Complete Pharma Product Lifecycle Guide: Discovery to Market

    Master each stage of the pharma product lifecycle—from discovery and trials to FDA approval and post-market safety—with this comprehensive industry overview.

  4. Drug Development | Clinical Center

    Bringing an investigational drug from bench to bedside is a long, complicated process involving many nonclinical and clinical investigations and layers of regulatory oversight. This page provides an easy …

  5. Understanding the Pharmaceutical Drug Development Life Cycle

    Apr 27, 2023 · The drug development life cycle is a complex but critical component of comprehensive healthcare and scientific advancement. The stakeholders' goal moving forward is to ensure that …

  6. Regulatory Affairs - Almac

    Regulatory Affairs With over 10 years of regulatory experience, our expert Regulatory Affairs team, based at our Global HQ, provides a broad range of tailored regulatory services to support: All phases …

  7. Strategic Regulatory Milestones in Drug Development Lifecycle ...

    Jul 22, 2025 · Step-by-step roadmap of regulatory involvement in pharmaceutical drug development lifecycle to reduce cost and accelerate time-to-market. Learn how early regulatory planning can cut …

  8. What is CMC in the Drug Development Process?

    Oct 6, 2025 · What Does CMC Mean in Drug Development? CMC refers to the technical and regulatory documentation that supports the identity, quality, purity, strength, and consistency of a drug product …

  9. EMA and FDA set common principles for AI in medicine development

    Jan 14, 2026 · EMA and the U.S. Food and Drug Administration (FDA) have jointly identified ten principles for good artificial intelligence (AI) practice in the medicines lifecycle. The principles give …

  10. FDA and EMA Align on Ten Principles to Guide Artificial ...

    Jan 29, 2026 · The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to …